Entropy Technologies, LP

Position in NVS — Novartis AG

CIK 1976151 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$5,729,369

+$3,841,532 QoQ

Shares Held

36,558

+195.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#246

of 1,603 holders

Holding Since

Dec 2024

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Entropy Technologies, LP holds $53,483,365 across 6 Drug Manufacturers - General names. NVS ranks #4 (10.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	64,317	$16,184,729
2	LLY	ELI LILLY & Co	11,052	$13,256,101
3	GILD	Gilead Sciences, Inc.	99,958	$12,628,693
4	NVS	Novartis AG This page	36,558	$5,729,369
5	GSK	GSK plc	58,582	$3,070,868
6	JNJ	Johnson & Johnson	10,291	$2,613,605

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,729,369	36,558	+195.8%	Shares	Sole	2026-08-13
2026-03-31	$1,887,837	12,359	+24.4%	Shares	Sole	2026-05-14
2024-12-31	$967,066	9,938	—	Shares	Sole	2025-01-28
No filing history on record for this holder in this stock.